Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Colorectal Cancer

Breast Cancer

Gastrointestinal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Colorectal Cancer

Multimodal Blood Test Successfully Screens for Advanced CRC, Adenomas

Shai Friedland, MD, discusses the importance of screening for colorectal cancer, the advantages of the noninvasive FirstSight^CRC blood test, and the results from the ZENITH trial.
Read More >>

Onvansertib Regimen Shows Early Promise in KRAS-Mutant mCRC

Nivolumab Plus Regorafenib Regimen Active in Gastrointestinal Cancers

Encorafenib/Cetuximab Combo Nears EU Approval for BRAF+ mCRC

FDA Approves Encorafenib/Cetuximab Combo for BRAF+ mCRC

Pembrolizumab Improves PFS in Frontline MSI-H/dMMR Colorectal Cancer

View More Stories >>

View Conference Coverage

2020 ESMO Breast Cancer Virtual Meeting

2020 ASCO Virtual Scientific Program

2020 International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

2020 AACR Annual Meeting

2020 SGO Annual Meeting

Dr. Mizrahi on Targeting Treatment in Metastatic Colorectal Cancer

Dr. Le on Research Needed to Address Unmet Needs in mCRC

Dr. Raghav on the Utility of ctDNA in CRC

Dr. Overman on Ongoing Research With Immunotherapy in Microsatellite Stable CRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Future Directions in I/O Therapy for mCRC

Immunotherapy in CRC

New Therapy Options for BRAF-Mutated mCRC

Management of Colorectal Cancer Metastases

TRIBE-2: FOLFOX or FOLFIRI With Bevacizumab in mCRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Novel Therapeutic Targets and Combinations in mCRC

MCRC: Future Directions for Molecular-Driven Treatment

Future Directions for Later-Line Therapy in R/R mCRC

Role of Immunotherapy in Microsatellite-Stable R/R mCRC

$Relapsed/Refractory mCRC: Immunotherapy in MSI-High Tumors$

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Treatment Goals in Refractory mCRC

$Treatment Goals in Refractory mCRC$
Tanios Bekaii-Saab, MD, FACP, Andrea Cercek, MD, and Zev A. Wainberg, MD, provide insight to the treatment goals for patients with refractory metastatic colorectal cancer.

View Now

Therapeutic Strategies in Metastatic Colorectal Cancer

Recent advances in the treatment of metastatic colorectal cancer (mCRC) have improved survival. However, many questions remain. Led by John L. Marshall, MD, panelists Tanios Bekaii-Saab, MD; Johanna Bendell, MD; Richard Kim, MD; and Charles S. Fuchs, MD, MPH, discuss strategies and approaches to managing mCRC, including the latest research and how it may influence clinical practice.

View Now

Featured Webinar

Live Broadcast on Metastatic Triple-Negative Breast Cancer